Innovation

Baylor team a finalist at international tech startup event


By Jeannette Jimenez | August 2, 2016

Two budding entrepreneurs at Baylor College of Medicine may have developed the next big advancement in cancer health care. Ravi Pathak and Hristijan Risteski, both members of Dr. Andrew Sikora’s lab in the department of otolaryngology, were among the top 10 finalists out of nearly 750 applicants presented at OneStart, the world’s largest life sciences and health care startup accelerator competition.

OneStart is a worldwide health care startup program where individuals looking to improve human health care with new innovative research tools, software, devices and diagnostics can apply to receive $150,000 to start their company.

Their budding start-up, Ovodex, seeks to commercialize a novel personalized medicine platform, which could allow clinicians to determine cancer treatments that are most effective for a given patient.

This year finalists were selected through a grueling three-step elimination process, in which participants were judged by a panel of executives from the leading pharmaceutical companies (Bristol-Myers Squibb, GSK, Roche, AstraZeneca), venture capital firms (Takeda Ventures, SR One) and consultancies (McKinsey & Co., Silicon Valley Bank).

Dr. Andrew Sikora, associate professor of otolaryngology and founder of Ovodex, praised the duo’s performance. “While Ovodex did not win the competition, making it to the finals is recognition of the promise and potential of the technology platform, and incredible journey from concept-to-product in a little over one year,” he said.

Pathak and Risteski presented an idea that would dramatically speed up the process of determining effective cancer treatments for specific patients.

“The great problem in cancer treatment is that more than 70 percent of the patients who are receiving standardized care are not responding to the treatment,” said Dr. Pathak. “Only three out of 10 patients see any effect based on the treatments they get, and that happens because of the different types of cancers they have, and also because of the individual genetic makeup.”

Every person facing cancer responds differently to treatment, so researchers have long worked on the concept of personalized medicine by removing a sample of a patient’s tumor and testing the response of these “patient-derived xenografts” (PDX) to different treatment options. Usually this approach is done by implanting the tumor in immunodeficient mice, which can take up to 6 months to obtain treatment results. Ovodex’s technology developed by Pathak has the potential to reduce this time frame to less than a month.

“We have developed a chicken egg-based model for making patient-derived xenografts,” said Pathak. “Using fertilized chicken eggs, we graft the patient’s tumor on the membrane that surrounds and nourishes the developing embryo. Within five to seven days, the tumor grows, and we are then able to expand it across multiple eggs to start testing for personalized medicine applications.”

In the past year, they have been able to grow tumors for seven different cancer types, including certain rare cancer types. In many cases, they have proven that the tumor grown on the egg was similar to the tumors growing inside the patient. They were also able to grow certain tumors that could not be grown in mice, thereby demonstrating the versatility, and efficacy of their method.

“Based on our calculations we should be able to come back to the patient within a month with all of the information about their treatment sensitivities – this is real-time personalized medicine,” said Pathak.

The new research minimizes time and cost. “This approach is rapid and cost-efficient. We don’t need a special animal facility to grow these tumors; with the eggs you can monitor them in a regular lab without any high tech instruments or lab facilities.”

This idea has helped launch their start-up company, Ovodex, whose advisory board includes Michael Lewis, associate professor in the Lester and Sue Smith Breast Center at Baylor and nationally-recognized expert on mouse-based PDX models.

Although they did not win the top prize with OneStart, both Pathak and Risteski plan to continue to expand their work to help better improve cancer treatment, and increase life expectancy under the guidance of Sikora.

Clinical trials are expected to start as soon as January 2017. The group has also started providing technical services for the faculty of Baylor College of Medicine as part of the Patient-Derived Xenografts and Advanced in Vivo Models Core.




Social Posts

profile_image

Veterans Affairs

@DeptVetAffairs

2018 marks the 100th Veteran's Day celebration https://t.co/qagt6ugIg4 via @WWLP22News

37 mins ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

“Embrace the patient community at MD Anderson. You’ll quickly realize you are not alone.” See where our #cancer survivors made important connections and found support: https://t.co/7k8ImVzP9H #endcancer https://t.co/UoDlCMzES3

56 mins ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

Several MD Anderson experts are presenting important developments in cancer care during the 2018 American Society for Radiation Oncologists conference, which kicks off today. #ASTRO18 #endcancer https://t.co/5XldQgZLBo

57 mins ago
profile_image

CHI St. Luke's Health

@CHI_StLukes

If you missed Mike’s Inside Story today in the Houston Chronicle, read how a heart transplant helped him return to his passion of landscape photography. https://t.co/PtrPPBUGN7Read more stories like Mike’s at https://t.co/Wqe3IeKGQr. https://t.co/KsA2K2rl3q

1 hour ago
profile_image

Veterans Affairs

@DeptVetAffairs

Manchester HS Invites All Veterans To Annual Honor Ceremony https://t.co/fjuKBX2PS8 @ManchstrNJPatch

2 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

Resource Social For Veterans and their families set for Nov. 1 https://t.co/42eYpZobMP via @IdahoStateJ

3 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

Struggling to resist that urge for a chocolate bar? Avoid temptation with these 5 tips from our dietitian Erma Levy: https://t.co/mJqM0IyrIp @FocusedonHealth #endcancer https://t.co/o29hv42JGi

3 hours ago
profile_image

University of Houston

@UHouston

RT @UHpres: Cougars beat Navy 49-36. Next up USF on Saturday, Oct 27th. Go Coogs!!

16 hours ago
profile_image

University of Houston

@UHouston

Ya woo @UHCougarFB wins!

16 hours ago
profile_image

University of Houston

@UHouston

RT @UHCougarFB: COOGS WIN! The #HTownTakeover defeats Navy, 49-36, to become bowl eligible at 6-1 overall and improve to 3-0 in @American_F…

16 hours ago
profile_image

UTHealth

@UTHealth

Dr. Pauline Rosenau of @UTexasSPH talks about the growing trend of "concierge" medicine and its implications for physicians and patients in this @HoustonChron story: https://t.co/F5GiUhhitK #publichealth #healthcare

17 hours ago
profile_image

BCMHouston

@bcmhouston

Learn how @BCM_SportsMed athletic trainer Meghan McKay stays fit. https://t.co/hwiYdYrMLE #healthy #habits

18 hours ago
profile_image

Rice University

@RiceUniversity

RT @RiceFootball: 🏈 𝐆𝐀𝐌𝐄 𝐃𝐀𝐘 🏈🆚 » @FIUFootball 📍 » Riccardo Silva Stadium ⏰ » 6:30PM CT 🖥 » ESPN+ 🔗 » https://t.co/apR29eo4Hf 📻 » @S…

19 hours ago
profile_image

Houston Methodist

@MethodistHosp

@ehaasmd Thanks for sharing the photos.

20 hours ago
profile_image

Houston Methodist

@MethodistHosp

@TheCAOG Thanks for sharing the photo.

20 hours ago